Tokai Hopes To Move $97M Suit Over IPO To Mass. Fed. Court
Tokai Pharmaceuticals Inc. Monday sought to move a putative class action by investors claiming it withheld important drug testing information prior to its $97 million initial public offering to a Massachusetts...To view the full article, register now.
Already a subscriber? Click here to view full article